Status:

Red

Decision Date:

November 2023

Comments

RED: NICE TA915 - Pegunigalsidase alfa for treating Fabry disease. NHSE commissioned (Decision date - November 2023)

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care

search again